Over 500 million men worldwide suffer from erectile dysfunction and premature ejaculation. Dicot Pharma is developing an entirely new potency drug aimed at creating a treatment with longer duration, fewer side effects, and effectiveness for a significantly broader group compared to existing market alternatives.
Dicot Pharma’s World in Numbers

Q2 report released – Watch the interview
The Interim Report for the second quarter was released on August 12. Watch CEO Elin Trampe and CFO Björn Petersson discuss and comment on the report in an interview with Direkt Studios.
Dutch TV highlights Swedish innovation
RTL’s channels reach 98% of the Dutch population every week. In one of their segments on innovative Swedish companies, Elin Trampe is interviewed about Dicot Pharma’s vision and the clinical work partly conducted in the Netherlands.
